Postural Tachycardia Syndrome (POTS) is a chronic disorder characterized by symptoms of orthostatic intolerance such as fatigue, lightheadedness, dizziness, palpitations, dyspnea, chest discomfort and remarkable tachycardia upon standing. Non-invasive transdermal vagal stimulators have been applied for the treatment of epilepsy, anxiety, depression, headache, and chronic pain syndromes. Anti-inflammatory and immunomodulating effects after transdermal vagal stimulation raised interest for applications in other diseases. Patients with sympathetic overactivity, reduced cardiac vagal drive and presence of systemic inflammation like POTS may benefit from tVNS. This article will address crucial methodological aspects of tVNS and provide preliminary results of its acute and chronic use in POTS, with regards to its potential effectiveness on autonomic symptoms reduction and heart rate modulation.

Transdermal auricular vagus stimulation for the treatment of postural tachycardia syndrome / A. Diedrich, V. Urechie, D. Shiffer, S. Rigo, M. Minonzio, B. Cairo, E.C. Smith, L.E. Okamoto, F. Barbic, A. Bisoglio, A. Porta, I. Biaggioni, R. Furlan. - In: AUTONOMIC NEUROSCIENCE: BASIC & CLINICAL. - ISSN 1566-0702. - 236(2021 Dec), pp. 102886.1-102886.10. [10.1016/j.autneu.2021.102886]

Transdermal auricular vagus stimulation for the treatment of postural tachycardia syndrome

B. Cairo;A. Porta;
2021

Abstract

Postural Tachycardia Syndrome (POTS) is a chronic disorder characterized by symptoms of orthostatic intolerance such as fatigue, lightheadedness, dizziness, palpitations, dyspnea, chest discomfort and remarkable tachycardia upon standing. Non-invasive transdermal vagal stimulators have been applied for the treatment of epilepsy, anxiety, depression, headache, and chronic pain syndromes. Anti-inflammatory and immunomodulating effects after transdermal vagal stimulation raised interest for applications in other diseases. Patients with sympathetic overactivity, reduced cardiac vagal drive and presence of systemic inflammation like POTS may benefit from tVNS. This article will address crucial methodological aspects of tVNS and provide preliminary results of its acute and chronic use in POTS, with regards to its potential effectiveness on autonomic symptoms reduction and heart rate modulation.
Autonomic function; Postural tachycardia syndrome; Vagal stimulation;
Settore ING-INF/06 - Bioingegneria Elettronica e Informatica
dic-2021
29-set-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
Diedrich_AN_2021.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 2.87 MB
Formato Adobe PDF
2.87 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/904764
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 24
  • OpenAlex ND
social impact